Method for preparing product of active lactic acid galactococcus
A Lactococcus lactis, active technology, applied in the field of preparation of Lactococcus lactis products, can solve the problems of low yield of Lactococcus lactis, low yield of expression products, limited practical application, etc., achieves good preservation effect, and prolongs logarithmic growth time. , the effect of reducing the cost of fermentation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Example 1: Preparation of genetically engineered Lactococcus lactis highly expressing phenylalanine deaminase
[0022] 1. Using the PAL gene fragment in the plasmid pET23b-PAL as a template, all the codons on the parsley PAL were changed to the preferred codons of Lactococcus lactis, and artificially synthesized to obtain PAL art , the primers used were:
[0023] T1: 5'-GAGAACGGTAACGGTGCAACTAC-3',
[0024] T2: 5'-GCTCTAGAGCATGTCAGTTAAC-3'.
[0025] T2 contains Xba I restriction site;
[0026] 2. PAL art After being treated with T4 DNA polymerase, it was digested with Xba I to obtain a cDNA fragment with preferred codons of Lactococcus lactis;
[0027] 3. Digest the expression vector pNZ8149 with Nco I, and connect it with the cDNA fragment with the preferred codon of Lactococcus lactis;
[0028] 4. Transforming competent Lactococcus lactis with the above-mentioned recombinant plasmid;
[0029] 5. Screen high-expression strains in transformed Lactococcus lactis;
...
Embodiment 2
[0036] Embodiment 2: Determination of PAL enzyme activity expressed by Lactococcus lactis in the present invention
[0037] The bacteria collected in Example 1 were prepared into a 1 mg / ml suspension with 0.1 mol / L borate buffer (containing 10 mM phenylalanine) at pH 8.8, reacted at 30° C. for 1 hour, and reacted at 0, 15, and 30 °C respectively. , 45, and 60 minutes to collect the reaction supernatant, use spectrophotometry to measure the amount of conversion product cinnamic acid, and calculate the specific activity of PAL enzyme in the bacteria.
Embodiment 3
[0038] Embodiment 3: Pharmacodynamic identification of the present invention for treating phenylketonuria
[0039] Feed the bacterium obtained in Example 1 of the present invention to the gene-deficient phenylketonuria model mice, and the usage is a single oral administration per day, 0.5g / only, for 7 consecutive days. The results show that the phenylketonuria in the blood of the treated mice The amino acid levels were significantly lower than those in the control mice, and there was a significant difference between the two groups (P<0.01).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com